Aging is something every person experiences, but scientists are still working to understand exactly why it happens and how it might be slowed down. As people grow older, the body gradually changes.
Energy levels may decline, muscles can become weaker, and the risk of developing chronic diseases increases. Conditions such as heart disease, diabetes, dementia, and certain cancers become more common with age.
Because of these challenges, researchers around the world are searching for ways to help people stay healthier for longer and extend not just lifespan, but also the number of years spent in good health.
One of the most promising approaches discovered by scientists is known as caloric restriction. This involves reducing the number of calories consumed while still providing the body with all the essential nutrients it needs. Over many decades, studies in a wide range of animals have shown that eating fewer calories can lead to longer life and better health.
Researchers have observed these benefits in organisms ranging from tiny worms and fruit flies to larger animals such as mice and monkeys.
Animals that follow calorie-restricted diets often develop fewer age-related diseases, maintain healthier body functions, and live longer than those that eat normally. These findings have made caloric restriction one of the most studied strategies in aging research.
Despite its potential benefits, caloric restriction is difficult for most people to follow. Maintaining a significantly reduced-calorie diet for years or even decades requires considerable effort and self-discipline.
Many people find it challenging to stick with such a lifestyle, and in some cases it may negatively affect quality of life. For these reasons, scientists have been searching for alternatives that could provide similar health benefits without requiring people to eat less.
This search has led researchers to investigate medications that may mimic the effects of caloric restriction. Several compounds, including metformin, rapamycin, and resveratrol, have attracted attention in recent years.
While some have shown promise in laboratory studies, each comes with limitations, potential side effects, or unanswered questions that make widespread long-term use challenging.
Now, researchers at the University of Liverpool have identified another intriguing possibility. They have discovered that a medication already used to treat high blood pressure may also help slow the aging process and improve health during aging.
The drug is called rilmenidine. For many years, doctors have prescribed rilmenidine to help lower blood pressure in people with hypertension. Because the medication has already been approved and used in clinical practice, researchers have extensive information about its safety and side effects.
In their study, the scientists tested rilmenidine in several animal models commonly used in aging research. These included worms, fruit flies, and mice. Although these animals are very different from humans, they provide valuable information because many of the biological processes involved in aging are surprisingly similar across species.
The results were encouraging. Animals that received rilmenidine generally lived longer than those that did not receive the drug. The treated animals also showed signs of better health throughout their lives. Importantly, these benefits appeared both in younger animals and in older ones, suggesting that the drug may support healthy aging at multiple stages of life.
What particularly excited the researchers was that the effects of rilmenidine closely resembled those seen with caloric restriction. In other words, the drug appeared to produce some of the same biological benefits that animals gain from eating fewer calories, even though their food intake was not reduced.
This raises the possibility that rilmenidine may act as what scientists call a “caloric restriction mimetic.” Such drugs are designed to trigger many of the same protective mechanisms activated by calorie restriction while allowing people to maintain a normal diet.
To better understand how rilmenidine produces these effects, the researchers investigated its actions at the cellular level. They identified a specific receptor known as the I1-imidazoline receptor, also called nischarin-1, as a key part of the process.
Receptors are molecules found on or inside cells that receive signals and help control various biological activities. The researchers believe that rilmenidine interacts with this receptor in a way that activates pathways associated with healthier aging and longer lifespan.
One of the most attractive aspects of this discovery is that rilmenidine is not a new experimental compound. Because it has already been used for many years to treat high blood pressure, researchers already know a great deal about its safety profile.
It is taken as a tablet and is generally well tolerated by patients. This could significantly speed up future research because scientists do not need to begin safety testing from scratch.
The study also highlights a growing trend in medical research known as drug repurposing. Instead of creating entirely new medications, researchers investigate whether existing drugs can be used for additional health conditions.
This approach often saves years of development time and reduces costs because the medications have already undergone extensive testing.
As populations around the world continue to age, finding ways to extend healthy lifespan is becoming increasingly important. Longer life expectancy has brought many benefits, but it has also increased the number of people living with chronic illnesses associated with aging.
Even modest improvements in healthy aging could reduce healthcare costs, improve quality of life, and help millions of people remain active and independent for longer.
However, the researchers caution that much more work remains to be done. While the findings in animals are promising, it is not yet known whether the same benefits will occur in humans.
Clinical studies will be needed to determine whether rilmenidine can safely and effectively slow aging in people and whether long-term use provides meaningful health advantages.
The study from the University of Liverpool adds to growing evidence that some existing medications may have unexpected benefits beyond their original purpose. It also provides fresh hope that scientists may eventually develop treatments that target aging itself rather than simply treating individual diseases after they appear.
If future human studies confirm these results, rilmenidine could become part of a new generation of therapies aimed at helping people stay healthier for longer. Such treatments could transform the way doctors approach aging and age-related diseases.
While that possibility remains in the future, this research offers an exciting glimpse into how a familiar medicine may one day help people enjoy longer, healthier lives.
If you care about high blood pressure, please read studies about unhealthy habits that may increase high blood pressure risk, and drinking green tea could help lower blood pressure.
For more information about high blood pressure, please see recent studies about what to eat or to avoid for high blood pressure, and 12 foods that lower blood pressure.
Copyright © 2026 Knowridge Science Report. All rights reserved.
